Elixinol Wellness Limited
ELLXF
$0.01
$0.0092.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.58M | 2.57M | 2.45M | 2.40M | 2.67M |
| Total Other Revenue | -7.50K | -7.50K | 7.40K | 7.20K | -- |
| Total Revenue | 2.57M | 2.56M | 2.46M | 2.40M | 2.67M |
| Cost of Revenue | 1.57M | 1.56M | 1.61M | 1.57M | 1.68M |
| Gross Profit | 1.00M | 1.00M | 849.40K | 831.80K | 983.30K |
| SG&A Expenses | 1.58M | 1.57M | 1.61M | 1.57M | 1.45M |
| Depreciation & Amortization | 117.50K | 117.10K | 163.70K | 160.30K | 164.50K |
| Other Operating Expenses | -90.60K | -90.30K | 114.70K | 112.30K | 132.30K |
| Total Operating Expenses | 3.17M | 3.16M | 3.49M | 3.42M | 3.43M |
| Operating Income | -597.90K | -596.00K | -1.04M | -1.02M | -761.40K |
| Income Before Tax | -965.50K | -962.40K | -990.70K | -970.10K | -832.80K |
| Income Tax Expenses | -175.60K | -175.00K | -- | -- | -1.17M |
| Earnings from Continuing Operations | -789.90K | -787.40K | -990.70K | -970.10K | 336.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -789.90K | -787.40K | -990.70K | -970.10K | 336.90K |
| EBIT | -597.90K | -596.00K | -1.04M | -1.02M | -761.40K |
| EBITDA | -508.70K | -507.10K | -915.10K | -896.10K | -760.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 290.26M | 290.26M | 222.16M | 222.16M | 184.36M |
| Average Diluted Shares Outstanding | 290.26M | 290.26M | 222.16M | 222.16M | 184.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |